Research Topic

Quality Assessment Across Disciplines in Head and Neck Cancer Treatment

About this Research Topic

Head and neck cancer is often a very complex and difficult cancer to treat, both because of the characteristics of head and neck squamous cell carcinomas (HNSCC), and the impact physically and mentally on the patient due to location and the treatment side effects. With many centers treating HNSCC, it is imperative that the quality of treatment of HNSCC is closely monitored and evaluated to ensure that patient outcomes are as positive as possible. Quality assurance of care should be irrelevant of where the cancer is diagnosed or treated. In this article collection, we will review the following areas for current best practice guidelines and possible areas of improvement:

• Diagnostic tumor markers in HNSCC in the clinical setting
• Diagnostic imaging in HNSCC
• Diagnostic pathology in HNSCC
• Best practice in surgical treatment of HNSCC
• Evidence for best practice chemotherapy treatment of HNSCC
• Best practice in Radiation treatment for HNSCC
• Follow up – how often and what should we check for?
• Supportive care in HNSCC
• The multidisciplinary team
• Impact on the guidelines – should there be a more centralised treatment plan of HNSCC?
• The statistical analysis of HNSCC treatment and outcomes


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Head and neck cancer is often a very complex and difficult cancer to treat, both because of the characteristics of head and neck squamous cell carcinomas (HNSCC), and the impact physically and mentally on the patient due to location and the treatment side effects. With many centers treating HNSCC, it is imperative that the quality of treatment of HNSCC is closely monitored and evaluated to ensure that patient outcomes are as positive as possible. Quality assurance of care should be irrelevant of where the cancer is diagnosed or treated. In this article collection, we will review the following areas for current best practice guidelines and possible areas of improvement:

• Diagnostic tumor markers in HNSCC in the clinical setting
• Diagnostic imaging in HNSCC
• Diagnostic pathology in HNSCC
• Best practice in surgical treatment of HNSCC
• Evidence for best practice chemotherapy treatment of HNSCC
• Best practice in Radiation treatment for HNSCC
• Follow up – how often and what should we check for?
• Supportive care in HNSCC
• The multidisciplinary team
• Impact on the guidelines – should there be a more centralised treatment plan of HNSCC?
• The statistical analysis of HNSCC treatment and outcomes


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

15 March 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

15 March 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top
);